CMS Cameron McKenna Nabarro Olswang LLP | United Kingdom | 21 Sep 2012
The High Court has refused to grant a stay of proceedings for infringement of a Community Trade Mark under Article 104(1) of the CTM Regulation where there were parallel proceedings before OHIM.
CMS Cameron McKenna Nabarro Olswang LLP | United Kingdom | 30 Sep 2011
Mr Justice Floyd has granted an application for an expedited trial in favour of Teva, in circumstances in which, if Teva succeeds in invalidating Warner-Lambert’s patent, Teva may obtain an advantage over other generic manufacturers of the drug atorvastatin, marketed by Warner-Lambert as Lipitor, one of the world’s most successful drugs with an annual turnover exceeding £350 million.